Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / UNIT 10/15/2029
-
Total 13F shares
-
3,289,223
-
Share change
-
+3,289,223
-
Total reported value
-
$33,388,110
-
Price per share
-
$10.17
-
Number of holders
-
15
-
Value change
-
+$33,388,110
-
Number of buys
-
15
Institutional Holders of Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) as of Q1 2025
As of 31 Mar 2025,
Drugs Made In America Acquisition Corp. - UNIT 10/15/2029 (DMAAU) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,289,223 shares.
The largest 10 holders included
HEIGHTS CAPITAL MANAGEMENT, INC, BOOTHBAY FUND MANAGEMENT, LLC, Westchester Capital Management, LLC, RIVERNORTH CAPITAL MANAGEMENT, LLC, Context Capital Management, LLC, Schonfeld Strategic Advisors LLC, Bulldog Investors, LLP, WOLVERINE ASSET MANAGEMENT LLC, Verition Fund Management LLC, and Parallax Volatility Advisers, L.P..
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.